WHY DO SOME PATIENTS HAVE HIGH DEFIBRILLATION THRESHOLDS AT DEFIBRILLATOR IMPLANTATION - ANSWERS FROM BASIC RESEARCH

被引:30
作者
HILLSLEY, RE
WHARTON, TM
CATES, AW
WOLF, PD
IDEKER, RE
机构
[1] DUKE UNIV, DEPT MED, DURHAM, NC USA
[2] DUKE UNIV, DEPT PATHOL, DURHAM, NC USA
[3] DUKE UNIV, SCH ENGN, ENGN RES CTR EMERGING CARDIOVASC TECHNOL, DURHAM, NC USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1994年 / 17卷 / 02期
关键词
IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; HIGH DEFIBRILLATION THRESHOLDS;
D O I
10.1111/j.1540-8159.1994.tb01375.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implantable cardioverter defibrillators reduce the risk of sudden cardiac death in patients with ventricular tachyarrhythmias. However, for the few patients with unacceptably high defibrillation thresholds at implantation the risk of sudden death may remain high. If a small number of defibrillation attempts are used to determine a defibrillation threshold, then a high defibrillation threshold may occur in some patients due to the probabilistic nature of defibrillation: a small percentage of shocks will fail even at optimal shock strengths. Basic investigations have suggested mechanisms for high defibrillation thresholds in other patients. The extracellular potential gradients produced by a shock correlate with ability to defibrillate and may be used to classify mechanisms for high defibrillation thresholds. Computerized mapping studies have demonstrated that extracellular potential gradient fields produced by defibrillation shocks are uneven with high gradient areas close to the electrodes and low gradient areas distant from the electrodes. A high defibrillation threshold may occur because: (2) a shock creates a subthreshold potential gradient in the low gradient areas; (2) a patient has a higher minimum potential gradient threshold than other patients; or (3) a shock leads to refibrillation in the high gradient areas. This article reviews experimental evidence to support each of these three possibilities then suggests experimental and clinical investigations that may clarify the causes of high defibrillation thresholds in patients.
引用
收藏
页码:222 / 239
页数:18
相关论文
共 122 条
  • [31] STRENGTH DURATION AND PROBABILITY OF SUCCESS CURVES FOR DEFIBRILLATION WITH BIPHASIC WAVE-FORMS
    FEESER, SA
    TANG, ASL
    KAVANAGH, KM
    ROLLINS, DL
    SMITH, WM
    WOLF, PD
    IDEKER, RE
    [J]. CIRCULATION, 1990, 82 (06) : 2128 - 2141
  • [32] AMIODARONE-INDUCED REFRACTORINESS TO CARDIOVERSION
    FOGOROS, RN
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) : 699 - 700
  • [33] THE EFFECT OF CHRONIC ORAL AND ACUTE INTRAVENOUS AMIODARONE ADMINISTRATION ON VENTRICULAR DEFIBRILLATION THRESHOLD USING IMPLANTED ELECTRODES IN DOGS
    FRAME, LH
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1989, 12 (02): : 339 - 346
  • [34] TRANSMURAL ACTIVATIONS AND STIMULUS POTENTIALS IN 3-DIMENSIONAL ANISOTROPIC CANINE MYOCARDIUM
    FRAZIER, DW
    KRASSOWSKA, W
    CHEN, PS
    WOLF, PD
    DANIELEY, ND
    SMITH, WM
    IDEKER, RE
    [J]. CIRCULATION RESEARCH, 1988, 63 (01) : 135 - 146
  • [35] EXTRACELLULAR FIELD REQUIRED FOR EXCITATION IN 3-DIMENSIONAL ANISOTROPIC CANINE MYOCARDIUM
    FRAZIER, DW
    KRASSOWSKA, W
    CHEN, PS
    WOLF, PD
    DIXON, EG
    SMITH, WM
    IDEKER, RE
    [J]. CIRCULATION RESEARCH, 1988, 63 (01) : 147 - 164
  • [36] SUCCESS OF CHRONIC DEFIBRILLATION AND THE ROLE OF ANTIARRHYTHMIC DRUGS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    GUARNIERI, T
    LEVINE, JH
    VELTRI, EP
    GRIFFITH, LSC
    WATKINS, L
    JUANTEGUY, J
    MOWER, MM
    MIROWSKI, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (13) : 1061 - 1064
  • [37] LV-MASS AND DEFIBRILLATION THRESHOLD
    HABERMAN, RJ
    MOWER, MM
    VELTRI, EP
    [J]. AMERICAN HEART JOURNAL, 1988, 115 (06) : 1340 - 1341
  • [38] HABERMAN RJ, 1988, J ELECTROPHYSIOL, V2, P415
  • [39] TRANSMEMBRANE ELECTRICAL POTENTIALS IN VENTRICULAR TACHYCARDIA AND FIBRILLATION
    HOGANCAMP, CE
    KARDESCH, M
    DANFORTH, WH
    BING, RJ
    [J]. AMERICAN HEART JOURNAL, 1959, 57 (02) : 214 - 222
  • [40] EFFECTS OF LONG-TERM AMIODARONE THERAPY ON THE DEFIBRILLATION THRESHOLD AND THE RATE OF SHOCKS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    HUANG, SKS
    DEGUZMAN, WLT
    CHENARIDES, JG
    OKIKE, O
    VANDERSALM, TJ
    [J]. AMERICAN HEART JOURNAL, 1991, 122 (03) : 720 - 727